ArticleDiabetologia2026
Diabetes heterogeneity beyond 3.8 years: missed risks of silent hypoglycaemia and long-term complications in the 4C study. Reply to Liu W, Deng B [letter].
Abstract readLetter
In one paragraph
Article in Diabetologia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Diabetes heterogeneity beyond 3.8 years: missed risks of silent hypoglycaemia and long-term complications in the 4C study. Reply to Liu W, Deng B [letter].Diabetologia · 2026Article
- Diabetes heterogeneity beyond 3.8 years: missed risks of silent hypoglycaemia and long-term complications in the 4C study.Diabetologia · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
48 authors.
Shuangyuan Wang *Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China.
Xiaojing Jia *Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China.
Yue Yin *Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China.
Hong Lin *Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China.
Yuanyue Zhu *Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China.
Yilan DingDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China.
Mian LiDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China.
Yu XuDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China.
Min XuDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China.
Feiyue HuangShanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Digital Medicine Innovation Center, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China.
Feixia ShenDepartment of Endocrine and Metabolic Diseases, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Xuejiang GuDepartment of Endocrine and Metabolic Diseases, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Yiming MuDepartment of Endocrine and Metabolic Diseases, Chinese People's Liberation Army General Hospital, Beijing, China.
Lulu ChenDepartment of Endocrine and Metabolic Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Tianshu ZengDepartment of Endocrine and Metabolic Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Lixin ShiDepartment of Endocrine and Metabolic Diseases, Affiliated Hospital of Guiyang Medical College, Guiyang, China.
Qing SuDepartment of Endocrine and Metabolic Diseases, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.
Xuefeng YuDepartment of Endocrine and Metabolic Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Li YanDepartment of Endocrine and Metabolic Diseases, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
Guijun QinDepartment of Endocrine and Metabolic Diseases, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Qin WanDepartment of Endocrine and Metabolic Diseases, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Gang ChenDepartment of Endocrine and Metabolic Diseases, Fujian Provincial Hospital, Fujian Medical University, Fuzhou, China.
Xulei TangDepartment of Endocrine and Metabolic Diseases, The First Hospital of Lanzhou University, Lanzhou, China.
Zhengnan GaoDepartment of Endocrine and Metabolic Diseases, Dalian Municipal Central Hospital, Dalian, China.
Ruying HuZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.
Zuojie LuoDepartment of Endocrine and Metabolic Diseases, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Yingfen QinDepartment of Endocrine and Metabolic Diseases, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Li ChenDepartment of Endocrine and Metabolic Diseases, Qilu Hospital of Shandong University, Jinan, China.
Xinguo HouDepartment of Endocrine and Metabolic Diseases, Qilu Hospital of Shandong University, Jinan, China.
Yanan HuoDepartment of Endocrine and Metabolic Diseases, Jiangxi provincial People's Hospital Affiliated to Nanchang University, Nanchang, China.
Qiang LiDepartment of Endocrine and Metabolic Diseases, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Guixia WangDepartment of Endocrine and Metabolic Diseases, The First Hospital of Jilin University, Changchun, China.
Yinfei ZhangDepartment of Endocrine and Metabolic Diseases, Central Hospital of Shanghai Jiading District, Shanghai, China.
Chao LiuDepartment of Endocrine and Metabolic Diseases, Jiangsu Province Hospital on Integration of Chinese and Western Medicine, Nanjing, China.
Youmin WangDepartment of Endocrine and Metabolic Diseases, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Shengli WuDepartment of Endocrine and Metabolic Diseases, Karamay Municipal People's Hospital, Xinjiang, China.
Tao YangDepartment of Endocrine and Metabolic Diseases, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Huacong DengDepartment of Endocrine and Metabolic Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Huapeng WeiShanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Digital Medicine Innovation Center, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China.
Jie ZhengDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China.
Tiange WangDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China.
Zhiyun ZhaoDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China.
Jiajun ZhaoDepartment of Endocrine and Metabolic Diseases, Shandong Provincial Hospital affiliated to Shandong University, Jinan, China.
Guang NingDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China.
Weiqing WangDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China.
Yufang BiDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China. byf10784@rjh.com.cn.ORCID http://orcid.org/0000-0002-4829-5915
Jieli LuDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China. jielilu@hotmail.com.ORCID http://orcid.org/0000-0003-1317-0896
4C Study Group
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Cardiovascular diseaseDDRTreeDiabetesHeterogeneityHypoglycaemia
Identifiers
PMID
41152495What Socratic holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.